The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study...
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
About this item
Full title
Author / Creator
Inoue, Takuya , Takagi, Hironori , Owada, Yuki , Watanabe, Yuzuru , Yamaura, Takumi , Fukuhara, Mitsuro , Muto, Satoshi , Okabe, Naoyuki , Matsumura, Yuki , Hasegawa, Takeo , Osugi, Jun , Hoshino, Mika , Higuchi, Mitsunori , Shio, Yutaka , Yokouchi, Hiroshi , Kanazawa, Kenya , Ohbuchi, Katsuya , Fukushima, Takahisa , Munakata, Mitsuru and Suzuki, Hiroyuki
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Cisplatin is a key drug in lung cancer therapy. However, cisplatin is also well known to induce gastrointestinal disorders, such as chemotherapy-induced nausea and vomiting, anorexia, and weight loss. These symptoms sometimes affect patients' quality of life and make continuation of chemotherapy difficult. Anorexia is a cause of concern for patient...
Alternative Titles
Full title
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
Authors, Artists and Contributors
Author / Creator
Takagi, Hironori
Owada, Yuki
Watanabe, Yuzuru
Yamaura, Takumi
Fukuhara, Mitsuro
Muto, Satoshi
Okabe, Naoyuki
Matsumura, Yuki
Hasegawa, Takeo
Osugi, Jun
Hoshino, Mika
Higuchi, Mitsunori
Shio, Yutaka
Yokouchi, Hiroshi
Kanazawa, Kenya
Ohbuchi, Katsuya
Fukushima, Takahisa
Munakata, Mitsuru
Suzuki, Hiroyuki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_aa2b23fcbd0c4b61ab1d0964408fef1d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aa2b23fcbd0c4b61ab1d0964408fef1d
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-017-2227-6
